305B2

Registration No. 333-158542

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM T-1

STATEMENT OF ELIGIBILITY UNDER
THE TRUST INDENTURE ACT OF 1939 OF A
CORPORATION DESIGNATED TO ACT AS TRUSTEE

þ Check if an Application to Determine Eligibility of
a Trustee Pursuant to Section 305(b)(2)

U.S. BANK NATIONAL ASSOCIATION

(Exact name of Trustee as specified in its charter)

31-0841368
I.R.S. Employer Identification No.

800 Nicollet Mall Minneapolis, Minnesota	55402
(Address of principal executive offices)	(Zip code)

Thomas E. Tabor
U.S. Bank Trust National Association
100 Wall Street, Suite 1600
New York, New York 10005
Telephone (212) 361-6184
(Name, address and telephone number of agent for service)

INVERNESS MEDICAL INNOVATIONS, INC.
(Exact name of Obligor as specified in its charter)
(See table of additional obligors on following page)

Delaware	04-3565120
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

51 Sawyer Road, Suite 200 Waltham, Massachusetts	02453
(Address of principal executive offices)	(Zip code)

Senior Subordinated Notes Due 2016
(Title of the Indenture Securities)

TABLE OF ADDITIONAL OBLIGORS

The following direct and indirect wholly owned domestic subsidiaries of Inverness Medical Innovations, Inc. are expected to guarantee the debt securities issued pursuant to the Indenture. The address, including zip code, and telephone number, including area code, of each of the co-obligors is 51 Sawyer Road, Suite 200, Waltham, Massachusetts, 02453, (781) 647-3900:

	State or Other
	Jurisdiction of	I.R.S. Employer
Exact Name of Additional Obligor	Incorporation or	Identification
as Specified in its Charter	Organization	Number
Advantage Diagnostics Corporation	Delaware	20-1247157
Alere LLC	Delaware	26-2564744
Alere Healthcare of Illinois, Inc.	Georgia	58-2068880
Alere Health Improvement Company	Delaware	23-2776413
Alere Health Systems, Inc.	Delaware	22-3493126
Alere Medical, Inc.	California	94-3238845
Alere Wellology, Inc.	Delaware	54-1776557
Alere Women’s and Children’s Health, LLC	Delaware	58-2205984
Ameditech Inc.	California	33-0859551
Applied Biotech, Inc.	California	33-0447325
Binax, Inc.	Delaware	20-2507302
Biosite Incorporated	Delaware	33-0288606
Cholestech Corporation	Delaware	94-3065493
First Check Diagnostics Corp.	Delaware	20-8329751
First Check Ecom, Inc.	Massachusetts	33-1026518
Forefront Diagnostics, Inc.	California	33-0733551
HemoSense, Inc.	Delaware	77-0452938
IM US Holdings, LLC	Delaware	26-0349667
Innovacon, Inc.	Delaware	20-1100264
Innovations Research, LLC	Delaware	20-0653511
Innovative Mobility, LLC	Florida	20-0351538
Instant Technologies, Inc.	Virginia	54-1837621
Inverness Medical, LLC	Delaware	26-0392649
Inverness Medical — Biostar Inc.	Delaware	91-1929582
Inverness Medical Innovations North America, Inc.	Delaware	26-1444559
Inverness Medical International Holding Corp.	Delaware	80-0077873
Inverness Medical International Holding Corp. II	Delaware	20-0963463
Ischemia Technologies, Inc.	Delaware	84-1489537
IVC Industries, Inc.	Delaware	22-1567481
Matritech, Inc.	Delaware	26-1436477
Ostex International, Inc.	Washington	91-1450247
Quality Assured Services, Inc.	Florida	59-3437644
Redwood Toxicology Laboratory, Inc.	California	68-0332937
RTL Holdings, Inc.	Delaware	20-4371685
Selfcare Technology, Inc.	Delaware	04-3383533
Wampole Laboratories, LLC	Delaware	37-1485678

FORM T-1

Item 1. GENERAL INFORMATION. Furnish the following information as to the Trustee.

a)	Name and address of each examining or supervising authority to which it is subject.
	Comptroller of the Currency — United States Department of the Treasury Washington, D.C. 20219
b)	Whether it is authorized to exercise corporate trust powers.
	Yes

Item 2. AFFILIATIONS WITH OBLIGOR. If the obligor is an affiliate of the Trustee, describe each such affiliation.

                         None

Items 3-15 Items 3-15 are not applicable, because to the best of the Trustee’s knowledge, the obligor is not in default under any Indenture for which the Trustee acts as Trustee.

Item 16. LIST OF EXHIBITS: List below all exhibits filed as a part of this statement of eligibility and qualification.

1.	A copy of the Articles of Association of the Trustee.*
2.	A copy of the certificate of authority of the Trustee to commence business.*
3.	A copy of the certificate of authority of the Trustee to exercise corporate trust powers.*
4.	A copy of the existing bylaws of the Trustee.**
5.	A copy of each Indenture referred to in Item 4. Not applicable.
6.	The consent of the Trustee required by Section 321(b) of the Trust Indenture Act of 1939, attached as Exhibit 6.
7.	Report of Condition of the Trustee as of December 31, 2008 published pursuant to law or the requirements of its supervising or examining authority, attached as Exhibit 7.
8.	Not applicable.
9.	Not applicable.

*	Incorporated by reference to Exhibit 25.1 to Amendment No. 2 to registration statement on S-4, Registration Number 333-128217 filed on November 15, 2005.
**	Incorporated by reference to Exhibit 25.1 to registration statement on S-4, Registration Number 333-145601 filed on August 21, 2007.

SIGNATURE

     Pursuant to the requirements of the Trust Indenture Act of 1939, as amended, the Trustee, U.S. BANK NATIONAL ASSOCIATION, a national banking association organized and existing under the laws of the United States of America, has duly caused this statement of eligibility and qualification to be signed on its behalf by the undersigned, thereunto duly authorized, all in the City of New York, State of New York on the 4^th of May, 2009.

By:	/s/ Thomas E. Tabor
	Thomas E. Tabor
	Vice President

EX-99.6

Exhibit 6

CONSENT

     In accordance with Section 321(b) of the Trust Indenture Act of 1939, the undersigned, U.S. BANK NATIONAL ASSOCIATION hereby consents that reports of examination of the undersigned by Federal, State, Territorial or District authorities may be furnished by such authorities to the Securities and Exchange Commission upon its request therefor.

Dated: May 4, 2009

By:	/s/ Thomas E. Tabor
	Thomas E. Tabor
	Vice President

EX-99.7

Exhibit 7
U.S. Bank National Association
Statement of Financial Condition
As of 12/31/2008

($000’s)

	12/31/2008
Assets
Cash and Balances Due From Depository Institutions	$	8,077,564
Securities		37,455,111
Federal Funds		3,290,350
Loans & Lease Financing Receivables		180,437,040
Fixed Assets		4,522,546
Intangible Assets		12,495,040
Other Assets		15,497,940
Total Assets	$	261,775,591
Liabilities
Deposits	$	171,980,048
Fed Funds		11,861,941
Treasury Demand Notes		0
Trading Liabilities		1,919,265
Other Borrowed Money		39,187,106
Acceptances		0
Subordinated Notes and Debentures		7,329,967
Other Liabilities		6,647,510
Total Liabilities	$	238,925,837
Equity
Minority Interest in Subsidiaries	$	1,664,422
Common and Preferred Stock		18,200
Surplus		12,597,620
Undivided Profits		8,569,512
Total Equity Capital	$	22,849,754
Total Liabilities and Equity Capital	$	261,775,591

To the best of the undersigned’s determination, as of the date hereof, the above financial information is true and correct.

U.S. Bank National Association
By:	/s/ Thomas E. Tabor
	Vice President

Date: May 4, 2009